This content is from: Premium
In a Tough Year, Viking Global Stages an October Comeback
Three major funds help put the firm in the black, despite a major bet on ravaged health care stocks, including Valeant Pharmaceuticals.
O. Andreas Halvorsen, Viking Global Investors (Bloomberg) Viking Global Investors posted decent gains across all three of its funds in October. Given its portfolio, this is a big victory. Viking Global Equities (VGE), its long-short fund, gained 1.1 percent for the month and is now up 5.2 percent for the year. Viking Long
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.